World Gene Therapy Congress 2012

Venue: Victoria Park Plaza

Location: London, United Kingdom

Event Date/Time: May 22, 2012 End Date/Time: May 23, 2012
Report as Spam


If your immediate goal is to uncover innovation and scientific advancement in gene therapy research and clinical development, then attendance at the World Gene Therapy Congress, Europe’s leading congress for thought leaders, practitioners and pioneers, is the solution to your scientific and strategic goals. Where do you stand on the road to commercialisation?
Pharma, Biotech and Academia attend to learn about:
• Strategies for developing Gene Therapy markets
• Synergistic Gene Therapy advances with other biotechnologies
• Research, development and product approval
• Molecular biological advances for Gene Therapy
• Technologies and classification of successful Gene Therapy techniques
• Clinical applications and scale of Gene Therapy
• Regulatory and safety advances of Gene Therapy
• Licensing and collaborative Gene Therapy approaches
• Financing R&D and investor involvement
Key speakers include:
• Alain Fischer, Head of the Research Unit, INSERM Institut National de la Santé et de la Recherche Médicale
• John Martin, CSO, Ark Therapeutics
• Sam Wadsworth, Head, Gene Therapy R&D, Genzyme a Sanofi Company
• Jörn Aldag, CEO, Amsterdam Molecular Therapeutics (ATM Biopharma)
• Maria Cristina Galli, Senior Researcher, EMA/CAT
• Frédéric Revah, CEO, Généthon
• Jane Farrar, CSO and Co-Founder, Genable Technologies


239 Vauxhall Bridge Road, London SW1V 1EQ , England
United Kingdom